MDxHealth SA Cash Flow from Financial Activities 2018-2025 | MDXH
MDxHealth SA cash flow from financial activities from 2018 to 2025. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
| MDxHealth SA Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2024 | $45 |
| 2023 | $32 |
| 2022 | $21 |
| 2021 | $67 |
| 2020 | $14 |
| 2019 | $18 |
| 2018 | $42 |
| 2017 | $0 |
| 2016 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.098B | $0.090B |
| MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.988B | 53.85 |
| Hims & Hers Health (HIMS) | United States | $13.954B | 144.98 |
| Tempus AI (TEM) | United States | $10.977B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.526B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.418B | 69.02 |
| Privia Health (PRVA) | United States | $3.048B | 208.33 |
| Enovis (ENOV) | United States | $2.027B | 11.30 |
| Clover Health Investments (CLOV) | United States | $1.832B | 0.00 |
| Schrodinger (SDGR) | United States | $1.721B | 0.00 |
| Phreesia (PHR) | United States | $1.510B | 0.00 |
| Omnicell (OMCL) | United States | $1.305B | 23.02 |
| Azenta (AZTA) | United States | $1.242B | 57.70 |
| 10x Genomics (TXG) | United States | $1.100B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.646B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.574B | 0.00 |
| Talkspace (TALK) | United States | $0.504B | 150.50 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Claritev (CTEV) | United States | $0.452B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.376B | 834.00 |
| Health Catalyst (HCAT) | United States | $0.271B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.231B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.144B | 0.00 |
| Pulmonx (LUNG) | United States | $0.134B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| CareCloud (CCLD) | United States | $0.088B | 3.34 |
| Outset Medical (OM) | United States | $0.070B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.013B | 0.00 |
| Precipio (PRPO) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |